physcione has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, R; Jia, D; Meng, Z; Wang, L; Wang, Y; Zhang, L; Zhou, T | 1 |
| Altucci, L; Basile, A; Bontempo, P; Conte, B; De Ruberto, F; Di Santi, A; Loppi, S; Molinari, AM; Nebbioso, A; Paoli, L; Rigano, D; Sorbo, S | 1 |
2 other study(ies) available for physcione and Breast Cancer
| Article | Year |
|---|---|
The anti-breast cancer property of physcion via oxidative stress-mediated mitochondrial apoptosis and immune response.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Emodin; Female; Humans; Immunity; Inhibitory Concentration 50; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Oxidative Stress; Xenograft Model Antitumor Assays | 2021 |
Antiproliferative, antibacterial and antifungal activity of the lichen Xanthoria parietina and its secondary metabolite parietin.
Topics: Anti-Bacterial Agents; Antifungal Agents; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Emodin; Female; Humans; Lichens; MCF-7 Cells; Plant Extracts; Rhizoctonia; Staphylococcus aureus | 2015 |